Healtcare Clinical Decision and Support System Market1

Increasing chronic disease prevalence worldwide to propel growth of the clinical decision support system market Increasing prevalence of the chronic disease such as cancer, diabetes, and cardiovascular disease worldwide is propelling demand for its accurate diagnosis, treatment plan, and continuous care. According to the data published by American Heart Association, in 2016, annual cost of cardiovascular disease and stroke in 2011 – 2012 was US$ 193.1 billion in medical care and about US$ 123 billion in lost productivity from premature death. This cost can be reduced by adopting clinical decision support system, which could prevent and control major risk factors for CVD such as hypertension, hypercholesterolemia, and diabetes. For More Information @ https://www.coherentmarketinsights.com/market-insight/clinical- decision-and-support-system-market-2054 However, CDSS system has few limitation in its operation, which may hinder growth of the clinical decision support system market. 1.CDSS must integrate with a healthcare provider’s clinical workflow, which is often complex task. Incorporating large amounts of data into existing systems places significant strain on application and infrastructure maintenance 2.Few clinical decision support systems ,which are stand-alone lack facility for integration with EHR system, which may lead to repetition of task 3.Updating development in clinical data on regular basis from ongoing clinical research and medical trials is challenging, as vast number of research and medical trials are being published every day. Key players are launching new products, which is expected to propel growth of the clinical decision support system market. In February 2018, the US Food and Drug Administration (FDA) granted marketing clearance for Viz.AI's Contact application. It is first Artificial Intelligence-based Clinical Decision Support (CDS) solution approved in the U.S. Integration of the Electronic Health Record(EHR), Computerized Physician Order Entry(CPOE) into CDSS by key players are expected to increase the adoption of the CDSS system, in turn driving growth of the clinical decision support system market. Furthermore, key players are entering into licensing deals with leading hospitals and healthcare groups to expand their consumer base and improve revenue prospects. Key players operating in the clinical decision support system market include Cerner Corporation, Allscripts Healthcare Solutions, Inc., IBM Watson Health, GE Healthcare, Change Healthcare, Zynx Health, Carestream Health Inc., First Databank, Inc., NextGen Healthcare Information Systems, Agfa Healthcare, Medical Information Technology Inc., Athena Health, Wolters Kluwer NU, Siemens Healthineers, and Philips Healthcare. Detailed Segmentation: •Global Clinical Decision Support System Market, By Product: •Stand Alone CDSS •Integrated CDSS •Global Clinical Decision Support System Market, By Component: •Hardware •Software

Healtcare Clinical Decision and Support System Market1 | Page 2